Initiating statin in elderly
WebbWhen we initiate statin treatment in patients with chronic liver disease we recommend complete alcohol abstinence, ... D.T. Projected real-worls effectiveness of using aggressive low-density lipoprotein cholesterol targets among elderly statin users following acute coronary syndromes in Canada. J. Am. Heart Assoc. 2024, 7, 1–12. WebbStatin therapy represents a substantial potential for safe, effective, and inexpensive primary prevention of ASCVD in elderly individuals (here defined as individuals >65 …
Initiating statin in elderly
Did you know?
Webbmeaning people who need statin therapy to prevent a second cardiovascular event. Real-life data show that in elderly subjects the maximum doses of statins are less likely to be prescribed than in younger patients [1]. A moderate dose of statin in elderly subjects may be preferred, to be well tolerated [1]. 3. Primary Prevention WebbOther potential risks of statin administration in the elderly include polypharmacy, drug–drug interactions, statin side effects, and cognitive limitations . There seems to be no problem with the financial cost-effectiveness . It has to be taken into account that real and perceived cardiovascular risk might differ in elderly patients .
Webb25 aug. 2024 · An emerging therapeutic approach in the treatment of infectious disease is to augment the host response through repurposing of well-tolerated, non-antibiotic, host-directed therapeutics. Earlier retrospective studies identify a positive association between statin use and a decreased risk of death due to sepsis or bacteremia. However, more … Webb1 okt. 2015 · Further, data on starting statin therapy for primary prevention are very limited for patients beyond age 75 years, with no evidence for patients in their 80s. 15 The evidence for statins (moderate intensity) in secondary prevention is stronger, and they should be considered regardless of age in secondary prevention. 15 Owing to …
WebbThere is no simple answer regarding statin use among older adults, and the existing data are conflicting. The decision to prescribe or deprescribe statins should be made on an individual basis. Factors such as a patient’s life expectancy should be weighed against ASCVD prevention. WebbStatin Use for Primary Prevention in the Elderly Population The CCS and the ACC/AHA guidelines both recommend discussion of statin use with elderly patients who are believed to be at higher risk. 2 , 4 , 5 , 69 There are randomized controlled trials currently underway specifically assessing statins in primary prevention in this population.
Webb19 apr. 2024 · Numerous large-scale randomized studies over the last 20 years have demonstrated the effectiveness of statins for reducing CV risk in primary and …
Webb10 feb. 2024 · Statins are frequently initiated in patients aged 80 years and older after an ischemic stroke, even though evidence on prevention of recurrent cardiovascular … paris calais mapssiemens bqd350WebbSome of the gaps in our current knowledge may be addressed by the upcoming STAREE trial (Statin Therapy for Reducing Events in the Elderly; NCT02099123), a randomized … siemens battery trainsWebb1 nov. 2024 · An updated draft of the United States Preventive Services Task Force (USPSTF) recommendations for aspirin use was released for public comment on October 12, 2024. 1,2 These guidelines have a grade C recommendation for initiating low-dose aspirin for primary prevention of cardiovascular disease in patients ages 40 to 59 … siemens btu meter priceWebb14 apr. 2024 · SOURCE: Lee AJ, Lee YJ, Heo JH, et al. Combination moderate-intensity statin and ezetimibe therapy for elderly patients with atherosclerosis. J Am Coll Cardiol 2024;81:1339-1349. P rior studies have shown older patients with atherosclerotic cardiovascular disease (ASCVD) benefit more from high-intensity statin therapy, but … paris beste restaurantsWebb23 mars 2024 · Statin therapy in elderly persons is a complex issue. Not only is the evidence scarce because of limited studies but there are also several barriers that intervene independent of the LDL-C lowering. siemens business services gmbh \u0026 co. ohgWebb19 okt. 2024 · One reason behind the therapeutic gap seen in elderly statin users may be the failure of the physician to titrate the patient to an optimal dose, mainly for fear of statin-induced myopathy. A retrospective cohort study analyzed databases that included 396,077 elderly residents in Ontario, Canada with coronary artery disease and diabetes, and … siemens breakfast excluded